{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:58:03Z","timestamp":1777553883936,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.7759\/cureus.22755","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T01:30:27Z","timestamp":1646184627000},"source":"Crossref","is-referenced-by-count":5,"title":["Ifosfamide as a Cause of Fanconi Syndrome"],"prefix":"10.7759","author":[{"given":"Daniel","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin","family":"Rodelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Pelaez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Fanconi syndrome in adulthood. The role of early diagnosis and treatment","author":"John W. Foreman","year":"2019","unstructured":"John W. Foreman. Fanconi syndrome in adulthood. The role of early diagnosis and treatment. Comprehensive Clinical Nephrology. ELSEVIER, 303-306; 2019. 6:586-594."},{"key":"ref2","article-title":"Fanconi syndrome in the adulthood. The role of early diagnosis and treatment","volume":"17","author":"Karatzas A","year":"2017","unstructured":"Karatzas A, Paridis D, Kozyrakis D, Tzortzis V, Samarinas M, Dailiana Z, Karachalios T. Fanconi syndrome in the adulthood. The role of early diagnosis and treatment. J Musculoskelet Neuronal Interact. 2017, 17:303-6.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct258","article-title":"Drug-induced renal Fanconi syndrome","volume":"107","author":"Hall AM","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014, 107:261-9. 10.1093\/qjmed\/hct258","journal-title":"QJM"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-016-1473-z","article-title":"Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature","volume":"186","author":"O'Sullivan D","year":"2017","unstructured":"O'Sullivan D. Late effects of chemotherapeutic agents on renal function in childhood cancer survivors: a review of the literature. Ir J Med Sci. 2017, 186:49-55. 10.1007\/s11845-016-1473-z","journal-title":"Ir J Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19951215)76:12<2557::aid-cncr2820761223>3.0.co;2-9","article-title":"A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults","volume":"76","author":"Ho PT","year":"1995","unstructured":"Ho PT, Zimmerman K, Wexler LH, et al.. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer. 1995, 76:2557-64. 10.1002\/1097-0142(19951215)76:12&lt;2557::aid-cncr2820761223&gt;3.0.co;2-9","journal-title":"Cancer"},{"key":"ref6","article-title":"Unexpected toxicity in patients treated with iphosphamide","volume":"32","author":"Van Dyk JJ","year":"1972","unstructured":"Van Dyk JJ, Falkson HC, Van der Merwe AM, Falkson G. Unexpected toxicity in patients treated with iphosphamide. Cancer Res. 1972, 32:921-4.","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012027","article-title":"Acquired Fanconi syndrome secondary to light chain deposition disease associated with monoclonal gammopathy of renal significance: A case report","volume":"97","author":"Tu H","year":"2018","unstructured":"Tu H, Mou L, Zhu L, Jiang Q, Gao DS, Hu Y. Acquired Fanconi syndrome secondary to light chain deposition disease associated with monoclonal gammopathy of renal significance: A case report. Medicine (Baltimore). 2018, 97:e12027. 10.1097\/MD.0000000000012027","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50037","article-title":"Drug-induced Fanconi's syndrome","volume":"41","author":"Izzedine H","year":"2003","unstructured":"Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Drug-induced Fanconi's syndrome. Am J Kidney Dis. 2003, 41:292-309. 10.1053\/ajkd.2003.50037","journal-title":"Am J Kidney Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000073350","article-title":"Pharmacology of ifosfamide","volume":"65 Suppl 2","author":"Furlanut M","year":"2003","unstructured":"Furlanut M, Franceschi L. Pharmacology of ifosfamide. Oncology. 2003, 65 Suppl 2:2-6. 10.1159\/000073350","journal-title":"Oncology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1021\/mp100329u","article-title":"New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2","volume":"8","author":"Ciarimboli G","year":"2011","unstructured":"Ciarimboli G, Holle SK, Vollenbr\u00f6cker B, et al.. New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2. Mol Pharm. 2011, 8:270-9. 10.1021\/mp100329u","journal-title":"Mol Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-007-0275-5","article-title":"Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule","volume":"82","author":"Yaseen Z","year":"2008","unstructured":"Yaseen Z, Michoudet C, Baverel G, Dubourg L. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule. Arch Toxicol. 2008, 82:607-14. 10.1007\/s00204-007-0275-5","journal-title":"Arch Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88861-ifosfamide-as-a-cause-of-fanconi-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:05Z","timestamp":1707507605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88861-ifosfamide-as-a-cause-of-fanconi-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.22755","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}